Search this blog:    Health  Society  Women



The new Alzheimer's drug: Why Donanemab, yet to be approved, has generated excitement

Within a year, a second drug has been found effective in checking cognitive decline in people with early Alzheimer's. Developed by the pharmaceutical giant Eli Lilly, Donanemab was found to slow down cognitive decline by 35% when compared with a ...


View article...


Top stories of the last 30 days